CIRRX | JABIX | CIRRX / JABIX | |
Total Expense Ratio | 1.25 | 0.80 | 156% |
Annual Report Gross Expense Ratio | 1.25 | 0.81 | 154% |
Fund Existence | 11 years | 5 years | - |
Gain YTD | 4.604 | -0.244 | -1,889% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.3B | 216M | 3,844% |
Annual Yield % from dividends | 2.37 | 2.01 | 118% |
Returns for 1 year | -1.51 | -2.08 | 72% |
Returns for 3 years | 32.71 | 19.63 | 167% |
Returns for 5 years | 26.75 | N/A | - |
Returns for 10 years | 55.42 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
UGMVX | 12.39 | N/A | N/A |
Victory Global Managed Volatility | |||
JFNSX | 69.95 | N/A | N/A |
Janus Henderson Global Life Sciences S | |||
JGSRX | 13.59 | N/A | N/A |
JHancock Global Shareholder Yield R2 | |||
AICCX | 66.37 | -0.16 | -0.24% |
American Funds Invmt Co of Amer C | |||
TSCGX | 18.42 | -0.24 | -1.29% |
Thrivent Small Cap Growth S |